APLM Apollomics Inc.

Nasdaq N/A


$ 15.61 $ -2.46 (-13.91 %)    

Thursday, 20-Nov-2025 14:28:18 EST
QQQ $ 590.50 $ -21.17 (-3.46 %)
DIA $ 460.07 $ -6.61 (-1.42 %)
SPY $ 656.90 $ -16.00 (-2.38 %)
TLT $ 89.21 $ 0.22 (0.25 %)
GLD $ 375.44 $ 0.26 (0.07 %)
$ 17.88
$ 17.68
$ 15.54 x 100
$ 16.87 x 24
$ 15.22 - $ 18.00
$ 3.66 - $ 42.12
7,284
na
19.73M
$ 0.54
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 apollomics-enters-into-settlement-agreement-with-twvc-goldlink-partners-investment-and-twvc-panglin-group-investment-to-pay-5m-in-cash-and-87975778-in-associated-legal-expenses

-SEC Filing

 apollomics-receives-39m-payment-from-launxp-maintains-active-collaboration-on-vebreltinib-development

Pursuant to the Company's Form 6-K filed on July 25, 2025 (the "July 2025 6-K"), Apollomics Inc. ("Apollomics&#...

 nasdaq-cancels-delisting-hearing-for-apollomics-confirms-compliance-with-continued-listing-standards

Apollomics Inc. (NASDAQ:APLM) ("Apollomics" or the "Company"), a California based late-stage clinical biopharma...

Core News & Articles

The Nasdaq Stock Market® (NASDAQ:NDAQ) announced that trading will resume in Apollomics Inc. Class A ordinary shares (NASDAQ:AP...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION